| Dr Brian Wetherington, MD | |
|
266 Joule St, Alcoa, TN 37701-2422 | |
| (865) 984-3864 | |
| (865) 380-4095 |
| Full Name | Dr Brian Wetherington |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 13 Years |
| Location | 266 Joule St, Alcoa, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184917635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | MD055614 (Tennessee) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | MD055614 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blount Memorial Physician Group Inc | 6406844174 | 242 |
| Volunteer Healthcare Services, Inc. | 8820003981 | 47 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted-in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).
A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.
With the continuing downward trend of federal funding for biomedical research, top scientists offer their own ideas.
Although most overweight adults agree that health insurance benefits designed to promote weight loss are a good idea, they don't want to pay extra for them, finds a new study in the American Journal of Preventive Medicine.
› Verified 3 days ago
| Entity Name | Blount Memorial Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710194 PECOS PAC ID: 6406844174 Enrollment ID: O20040503000547 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted-in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).
A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.
With the continuing downward trend of federal funding for biomedical research, top scientists offer their own ideas.
Although most overweight adults agree that health insurance benefits designed to promote weight loss are a good idea, they don't want to pay extra for them, finds a new study in the American Journal of Preventive Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Wetherington, MD 103 W Broadway Ave, Maryville, TN 37801-4703 Ph: (865) 273-1752 | Dr Brian Wetherington, MD 266 Joule St, Alcoa, TN 37701-2422 Ph: (865) 984-3864 |
News Archive
New research by scientists at Columbia University suggests that boosting the function of a certain enzyme may provide a promising strategy for battling Alzheimer's disease, and possibly reversing its effects.
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted-in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).
A clinical trial with 149 patients suffering from the very disabling autoimmune disease systemic lupus erythematosus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.
With the continuing downward trend of federal funding for biomedical research, top scientists offer their own ideas.
Although most overweight adults agree that health insurance benefits designed to promote weight loss are a good idea, they don't want to pay extra for them, finds a new study in the American Journal of Preventive Medicine.
› Verified 3 days ago